Cat: IPD-X33919

Recombinant Human Carbonic Anhydrase 8 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    Carbonic Anhydrase 8

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    CAVIII; CA-VIII; CALS; CARP; Carbonic anhydrase-related protein

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    N-His

  • 纯度

    Greater than 95% as determined by SDS-PAGE.

  • 蛋白编号

    P35219

  • 表达区间

    Met1~Gln290

  • 分子量

    37kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Carbonic Anhydrase 8 (CA8) is a member of the carbonic anhydrase enzyme family, which plays a crucial role in regulating pH and CO2 levels in biological systems. This enzyme is predominantly expressed in the brain and testis, where it is implicated in several physiological processes, including neurotransmission and ion transport. Recent studies have highlighted CA8's involvement in conditions such as neurological disorders and cancer, making it a target of interest for therapeutic interventions. However, the lack of detailed structural and functional information has hindered a comprehensive understanding of CA8's mechanisms of action. To address this knowledge gap, researchers have turned to recombinant protein technology to produce CA8 in a controlled laboratory setting. This approach allows for the generation of large quantities of the enzyme, enabling various biochemical and biophysical analyses. Recombinant CA8 can be utilized to investigate its catalytic properties, interaction with potential inhibitors, and role in cellular pathways. Additionally, characterizing the enzyme's structure through techniques such as crystallography or nuclear magnetic resonance can provide insights into its active site and substrate specificity. Ultimately, the study of recombinant CA8 holds promise for unveiling its biological functions and establishing its potential as a therapeutic target, which could lead to the development of novel treatments for diseases associated with its dysregulation.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US